BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19383808)

  • 21. [Interceptors:--"silent" chemokine receptors].
    Grodecka M; Waśniowska K
    Postepy Hig Med Dosw (Online); 2007; 61():231-9. PubMed ID: 17507871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Duffy antigen receptor for chemokines attenuates breast cancer growth and metastasis: an experiment with nude mice].
    Wang J; Ou ZL; Hou YF; Luo JM; Chen Y; Zhou J; Shen ZZ; Ding J; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2033-7. PubMed ID: 16313795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered levels of plasma chemokines in breast cancer and their association with clinical and pathological characteristics.
    Narita D; Seclaman E; Anghel A; Ilina R; Cireap N; Negru S; Sirbu IO; Ursoniu S; Marian C
    Neoplasma; 2016; 63(1):141-9. PubMed ID: 26639244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-translational control of chemokines: a role for decoy receptors?
    Comerford I; Nibbs RJ
    Immunol Lett; 2005 Jan; 96(2):163-74. PubMed ID: 15585320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of chemokine decoy receptors and their ligands at the porcine maternal-fetal interface.
    Wessels JM; Linton NF; van den Heuvel MJ; Cnossen SA; Edwards AK; Croy BA; Tayade C
    Immunol Cell Biol; 2011 Feb; 89(2):304-13. PubMed ID: 20680026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system.
    Comerford I; Harata-Lee Y; Bunting MD; Gregor C; Kara EE; McColl SR
    Cytokine Growth Factor Rev; 2013 Jun; 24(3):269-83. PubMed ID: 23587803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of chemokine receptors in organ-specific metastasis.
    Zlotnik A
    Contrib Microbiol; 2006; 13():191-199. PubMed ID: 16627966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.
    Wang LP; Cao J; Zhang J; Wang BY; Hu XC; Shao ZM; Wang ZH; Ou ZL
    Med Oncol; 2015 Nov; 32(11):254. PubMed ID: 26487662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemokine and chemokine receptors: a comparative study between metastatic and nonmetastatic lymph nodes in breast cancer patients.
    Razmkhah M; Jaberipour M; Safaei A; Talei AR; Erfani N; Ghaderi A
    Eur Cytokine Netw; 2012; 23(3):72-7. PubMed ID: 23078970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
    Yu KD; Wang X; Yang C; Zeng XH; Shao ZM
    Oncotarget; 2015 Sep; 6(28):26519-27. PubMed ID: 26314842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell Lines.
    Zhang Z; Sun T; Chen Y; Gong S; Sun X; Zou F; Peng R
    DNA Cell Biol; 2016 Jul; 35(7):348-57. PubMed ID: 27008282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemokine and chemokine receptor related to cancer metastasis].
    Yanagie H; Hisa T; Ono M; Eriguchi M
    Gan To Kagaku Ryoho; 2010 Nov; 37(11):2052-7. PubMed ID: 21084802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coy decoy with a new ploy: interceptor controls the levels of homeostatic chemokines.
    Haraldsen G; Rot A
    Eur J Immunol; 2006 Jul; 36(7):1659-61. PubMed ID: 16791884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemokines, chemokine receptors, and cancer metastasis.
    Kakinuma T; Hwang ST
    J Leukoc Biol; 2006 Apr; 79(4):639-51. PubMed ID: 16478915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemokines and their role in tumor growth and metastasis.
    Wang JM; Deng X; Gong W; Su S
    J Immunol Methods; 1998 Nov; 220(1-2):1-17. PubMed ID: 9839921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokines in tumor angiogenesis and metastasis.
    Singh S; Sadanandam A; Singh RK
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):453-67. PubMed ID: 17828470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
    Soria G; Yaal-Hahoshen N; Azenshtein E; Shina S; Leider-Trejo L; Ryvo L; Cohen-Hillel E; Shtabsky A; Ehrlich M; Meshel T; Keydar I; Ben-Baruch A
    Cytokine; 2008 Oct; 44(1):191-200. PubMed ID: 18790652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical chemokine receptor D6 inhibits human non-small cell lung cancer growth by sequestration of chemokines.
    Wu FY; Fan J; Tang L; Zhao YM; Zhou CC
    Oncol Lett; 2013 Jul; 6(1):91-95. PubMed ID: 23946783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iroquois homeobox 2 suppresses cellular motility and chemokine expression in breast cancer cells.
    Werner S; Stamm H; Pandjaitan M; Kemming D; Brors B; Pantel K; Wikman H
    BMC Cancer; 2015 Nov; 15():896. PubMed ID: 26560478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.
    Dewan MZ; Ahmed S; Iwasaki Y; Ohba K; Toi M; Yamamoto N
    Biomed Pharmacother; 2006 Jul; 60(6):273-6. PubMed ID: 16828253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.